Pharmacy benefits manager (PBM) RxPreferred has announced plans to offer the Humira biosimilar Yusimry through Mark Cuban Cost Plus Drugs – an online pharmacy launched by celebrity investor and ...
Billionaire and celebrity entrepreneur Mark Cuban has revealed his latest move to tackle the cost of medicines in the US, agreeing a deal to make a low-cost biosimilar version of AbbVie’s blockbuster ...
Insiders, however, paint a different picture, alleging the directors, facing the likelihood of no term extensions chose a dramatic exit to shape the narrative in their favor. In a theatrical exit that ...
Provident Financial Services remains a 'buy' despite recent underperformance versus the S&P 500, supported by strong year-over-year growth and a successful merger. PFS has grown deposits and loans, ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Hosted on MSN
Coherus Biosciences Divests UDENYCA Business
An update from Coherus Biosciences ( (CHRS)) is now available. On April 11, 2025, Coherus Biosciences sold its UDENYCA business, marking a significant divestiture of its biosimilar businesses, which ...
About Provident Financial Services Inc. Provident Financial Services, Inc. is a holding company, which engages in the provision of banking services to individual and corporate customers in Northern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback